Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lewis Acid Catalyzed Ring Opening. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101463063B reveals a green Lewis acid/water method for amino steroid intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel patent CN111499536A details a safe, scalable benzylamine route for oseltamivir intermediates, offering significant cost and safety advantages for pharmaceutical manufacturing.
Patent CN114195754B reveals a novel catalytic route for S-(-)-4-chloromethyl-2,2-dimethyl-1,3-dioxolane, offering superior chiral purity and scalable manufacturing for pharmaceutical intermediates.
Novel Lewis acid catalyzed route for Brivaracetam intermediate. High purity, scalable process avoiding hazardous halogenation for reliable supply.
Discover a novel synthesis for Oseltamivir intermediate impurity standards. Enhance quality control with high-purity reference materials via mild catalytic processes.